Literature DB >> 20439214

Understanding weight loss in patients with colorectal cancer: a human response to illness.

Sunita Bayyavarapu Bapuji1, Jo-Ann V Sawatzky.   

Abstract

PURPOSE/
OBJECTIVES: To provide a comprehensive overview of weight loss in patients with colorectal cancer (CRC) within the context of the Human Response to Illness (HRTI) model. DATA SOURCES: Research from 1990-2008 and classic research from the 1980s were included. PubMed, CINAHL(R), and Google Scholar were searched for the terms cancer, CRC, weight loss, and cancer cachexia. DATA SYNTHESIS: Progressive, unintentional weight loss is a common issue in patients with CRC that has a devastating effect on patients' self-image, quality of life, and survival. Physiologic abnormalities, responses to the tumor, and treatments contribute to weight loss in these patients. In addition, cancer cachexia is an end-stage wasting syndrome and a major cause of morbidity and mortality in this population.
CONCLUSIONS: The HRTI model provides an appropriate framework to gain a comprehensive understanding of the physiologic, pathophysiologic, behavioral, and experiential perspectives of weight loss and cancer cachexia in patients with CRC. IMPLICATIONS FOR NURSING: By examining weight loss in patients with CRC within the context of the four perspectives of the HRTI model, oncology and gastroenterology nurses can gain insight into optimal, evidence-based assessment and management of this patient population. In addition, current gaps in knowledge can be identified and provide guidance for future nursing research.

Entities:  

Mesh:

Year:  2010        PMID: 20439214     DOI: 10.1188/10.ONF.303-310

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  4 in total

1.  Factors affecting the assessment of cancer cachexia by nurses caring for patients with advanced cancer undergoing chemotherapy: A cross-sectional survey.

Authors:  Rika Sato; Naoko Hayashi; Naoko Nakayama; Aiko Okimura
Journal:  Asia Pac J Oncol Nurs       Date:  2022-04-28

2.  Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways.

Authors:  Rafael Barreto; Giorgia Mandili; Frank A Witzmann; Francesco Novelli; Teresa A Zimmers; Andrea Bonetto
Journal:  Front Physiol       Date:  2016-10-19       Impact factor: 4.566

3.  Chemotherapy-induced cachexia and model-informed dosing to preserve lean mass in cancer treatment.

Authors:  Suzan Farhang-Sardroodi; Michael A La Croix; Kathleen P Wilkie
Journal:  PLoS Comput Biol       Date:  2022-03-21       Impact factor: 4.475

4.  Sociodemographic and economic factors are associated with weight gain between before and after cancer diagnosis: results from the prospective population-based NutriNet-Santé cohort.

Authors:  Philippine Fassier; Laurent Zelek; Patrick Bachmann; Marina Touillaud; Nathalie Druesne-Pecollo; Valentin Partula; Serge Hercberg; Pilar Galan; Patrice Cohen; Hélène Hoarau; Paule Latino-Martel; Bernard Srour; Rebeca Gonzalez; Mélanie Deschasaux; Mathilde Touvier
Journal:  Oncotarget       Date:  2017-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.